BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
27 févr. 2024 15h52 HE
|
BioAegis Therapeutics
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
20 déc. 2023 08h53 HE
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
BioAegis Therapeutics Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
16 oct. 2023 14h40 HE
|
BioAegis Therapeutics
Partnership supports execution of a large phase 2 global study to evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. NORTH BRUNSWICK, N.J., Oct....
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
16 oct. 2023 07h30 HE
|
ContraFect Corporation
YONKERS, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...
Global Antimicrobial Susceptibility Testing Market 2023-2030: Unveiling Treatment Efficacy - Antimicrobial Susceptibility Testing Market Soars with Focus on Personalized Medicine
08 sept. 2023 06h28 HE
|
Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Antimicrobial Susceptibility Testing Market Size, Share & Trends Analysis Report By Product, By Technique, By Application, By End-use, By Region,...
Pneumonia Testing Industry Landscape 2023-2030: U.S. and China Leading the Way
27 juil. 2023 07h18 HE
|
Research and Markets
Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "Pneumonia Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market analysis for...
Mycoplasma Testing Global Market to 2030: Rising Cell Culture Contamination Drives Growth
06 juil. 2023 06h48 HE
|
Research and Markets
Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "Mycoplasma Testing Market Size, Share & Trends Analysis By Product (Instruments, Kits & Reagents), By Technology (PCR, ELISA, Direct Assay,...
$43.1 Billion Point-of-Care Diagnostics Markets by Platform, Application, Sample Type, and End User - Global Forecast to 2030
01 juin 2023 09h23 HE
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood...
Global Legionella Testing Market Analysis & Epidemiology Report, 2016-2022 & 2023-2031
26 mai 2023 07h53 HE
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Global Legionella Testing Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global legionella...
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
15 mai 2023 16h15 HE
|
OpGen, Inc.
Total revenue for the first quarter of 2023 was approximately $0.91 million, an increase of approximately 94% compared to the first quarter of 2022Expanded U.S. growth opportunities with the Unyvero...